Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Therapeutics Board Director Mats Blom Acquires 200,000 Shares

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    31/05/2023 14:07
    May 31 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * MATS BLOM, BOARD DIRECTOR OF CO, HAS ACQUIRED 200,000
ADDITIONAL
SHARES IN CO ON MAY 31, 2023

Source text for Eikon:  ID:nMFN1c4Pvn 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news